iRay Group (SHA:688301)

China · Delayed Price · Currency is CNY

97.15

-3.79 (-3.75%)

Aug 24, 2026, 3:00 PM CST

21.76% (1Y)

Market Cap	30.43B +36.3%
Revenue (ttm)	2.86B +52.5%
Net Income	721.10M +46.5%
EPS	2.41 +39.9%
Shares Out	313.28M
PE Ratio	40.36
Forward PE	31.56
Dividend	0.71 (0.74%)
Ex-Dividend Date	Jun 12, 2026

Volume	4,805,950
Open	100.17
Previous Close	100.94
Day's Range	95.55 - 100.90
52-Week Range	68.29 - 153.29
Beta	0.90
Analysts	Strong Buy
Price Target	125.17 (+28.84%)
Earnings Date	Aug 14, 2026

About iRay Group

iRay Group, together with its subsidiaries, researches, develops, produces, sells, and services x-ray system components and micro-display backplanes for use in medical, dental, oncology, veterinary, security, and nondestructive testing applications in China and internationally. The company offers wireless and tethered radiography, mammography, and dynamic/real-time detectors; linear detector arrays; X-ray and micro focus X-ray sources; high voltage generators; radiation detecting materials; software; and other products. It is also involved in t... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2011

Employees 2,292

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688301

Full Company Profile

Financial Performance

In 2025, iRay Group's revenue was 2.25 billion, an increase of 22.90% compared to the previous year's 1.83 billion. Earnings were 650.01 million, an increase of 39.73%.

Financial Statements

Analyst Summary

According to 10 analysts, the average rating for 688301 stock is "Strong Buy." The 12-month stock price target is ¥125.17, which is an increase of 28.84% from the latest price.

Price Target

¥125.17

(28.84% upside)

Analyst Consensus: Strong Buy

Stock Forecasts